Skip to main content
Equibles

ANNX · Annexin Pharmaceuticals AB (publ) · Investor Relations

Use ANNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
8.7600 SEK -0.1800 (-2.01%) At close · Oct 7
Rebalance outlook locked
Market Cap
78.29M SEK
Shares
8.72M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-09-22 CEO Anders Haegerstrand presents at Biostock’s event Investing in Life Science, Stockholm September 22, 2026 (Eng) Event
2026-06-10 CEO Anders Haegerstrand presenting at Aktiedagarna Stockholm, 10 June 2026 (swe) Event
2026-05-21 CEO Anders Haegerstrand presenting at Biostock Global Forum 2026, 21 May 2026 (eng) Event
2026-04-22 CEO Anders Haegerstrand presenting at the Life Science Investor Conference, Økonomisk Ugebrev A/S, Copenhague, April 22, 2026 (eng) Conference
2026-04-15 CEO Anders Haegerstrand presenting at Redeye Healthcare Day, 15 April, 2026 (eng) Event
2025-11-12 CEO Anders Haegerstrand presenting at Biostock Life Science Summit in Lund, 12 November 2025 (eng) Event
2025-07-29 CSO/CMO Anna Frostegård presenting at OISRetina2025 in Orlando, USA, 29 July 2025 (eng) Event
2025-06-11 CEO Anders Haegerstrand presenterar på Redeye Investor Forum i Stockholm, 11 juni 2025 (sve) Event
2025-05-20 CEO Anders Haegerstrand presenting at Biostock Global Forum 2025 in Lund, 20 May 2025 (eng) Event
2025-03-12 CEO Anders Haegerstrand presenterar på Aktiespararnas Stora Aktiedagarna, 12 mars 2025 (sve) Event
2025-03-07 CEO Anders Haegerstrand presenterar hos BioStock, 7 mars 2025 (sve) Event
2025-03-06 CEO Anders Haegerstrand presenterar på Redeye Investor Forum Online, 6 mars 2025 (sve) Event
2025-01-22 CEO Anders Haegerstrand presenting at Redeye Fight Cancer event in Stockholm, 22 January 2025 (eng) Event
2024-12-03 CSO/CMO Anna Frostegård presenting at Redeye Technology & Life Science day, 3 December 2024 (eng) Event
2024-11-21 CEO Anders Haegerstrand presenting at BioStock Life Science Summit in Lund, 21 November 2024 (eng) Event
2024-11-07 CEO Anders Haegerstrand presenterar på Redeye Investor forum i Göteborg, 7 november 2024 (swe) Event
2024-09-12 Biostock Vator Securities Event – Investing in Life Science 2024 – From Seed to Success, 12 September 2024 Event
2024-09-12 Biostock Vator Securities event – 5 min CEO interview with Anders Haegerstrand, 12 September 2024 (eng) Event
2024-08-27 Biostock interview on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 27 August 2024 Event
2024-08-22 Interview at Redeye on topline data with our CEO Anders Haegerstrand & CSO/CMO Anna Frostegård, 22 August 2024 Event
2024-05-31 CEO Anders Haegerstrand & CSO/CMO Anna Frostegård presenterar på Redeye Growth Day 2024, 31 maj 2024 Event
2024-05-16 CSO/CMO Anna Frostegård presenterar hos Redeye, 16 maj 2024 Event
2024-04-29 CSO/CMO Anna Frostegård & CEO Anders Haegerstrand intervju om sista patienten behandlad i Annexins RVO studie – lovande effektsignaler och inga säkerhetsproblem, 29 april 2024 Event
2023-11-23 CEO Anders Haegerstrand presenterar på Redeye’s Life Science Day, 23 november 2023 Event
2023-10-25 CEO Anders Haegerstrand presenterar hos Økonomisk Ugebrev A/S i Köpenhamn 25 oktober, 2023 Event

Source: https://annexinpharma.se/investerare/